全球生命科学
概述
Featured News & Insights
0017
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort
Capabilities
Related Resources
Related Blogs
News & Insights
Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Life Sciences College 2026Thursday, February 12, 2026Sidley Commended in Chambers Global 2026February 12, 2026Legal Issues Arising From the Use of Artificial Intelligence in Drug DevelopmentFebruary 11, 2026
活动
活动
荣誉
Drug Discovery World
OIG Releases Long-Awaited Medicare Advantage Compliance Program GuidanceFebruary 10, 2026Medical Products Market Access: Favorable Advisory Opinion Reaffirms Discounting FlexibilitiesJanuary 21, 2026Top 10 FDA Areas We Are Watching For 2026January 12, 2026Impact of U.S. FDA Warning Letters in Europe: Practical Considerations for IndustryJanuary 12, 2026
Global Life Sciences Update
Global Life Sciences Update
盛德动态
Food, Drug, and Medical Device Update
Legal Issues Arising From the Use of Artificial Intelligence in Drug DevelopmentFebruary 11, 2026DOJ Announces Renewal of FCA Working GroupOctober 2025False Claims Act Liability: When Do Claims for Health Care Reimbursement 'Result From' Anti-Kickback Statute Violations?September 25, 2025Department of Health and Human Services Office of General Counsel Statement of Organization Suggests Potential Consolidation, Expansion of AuthoritySeptember – October 2025
Drug Discovery World
Pratt’s Government Contracting Law Report
Reuters
The Journal of Federal Agency Action
Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Life Sciences College 2026Thursday, February 12, 2026U.S. Clinical Trial Design & Execution RisksThursday, January 29, 2026Sidley's 2026 San Diego Clinical Trial SeriesThursday, January 29, 2026 | Thursday, March 12, 2026 | Tuesday, April 21, 2026
活动
活动
活动
活动
Sidley Represents SanegeneBio in up to US$1.5 Billion Licensing Agreement With GenentechFebruary 10, 2026Sidley Represents Vivo Capital on Its Acquisition of Dutscher GroupFebruary 4, 2026Sidley Represents AdvanCell in Collaboration and Exclusive Licensing Agreement With 48Hour DiscoveryFebruary 3, 2026Sidley Represents RoundTable Healthcare Partners in Its Partnership and Investment in ColorescienceFebruary 2, 2026
公告
公告
公告
公告
Delaware Supreme Court Makes Earnouts Less Risky For Buyers Earnout Decision Partially Reversed Because Buyer Did Not Have to Pursue an Alternative Regulatory PathwayJanuary 27, 2026FY 2025 FCA Settlements and Judgments Statistics Show Highest Recoveries EverJanuary 20, 2026U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025
GoodLifeSci
Original Source
GoodLifeSci
GoodLifeSci









































